Laura Sutcliffe
Stock Analyst at UBS
(1.30)
# 3,506
Out of 4,944 analysts
7
Total ratings
57.14%
Success rate
-7.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintains: Buy | $285 → $325 | $283.29 | +14.72% | 2 | Aug 1, 2025 | |
| TLX Telix Pharmaceuticals | Maintains: Buy | $21 → $22 | $10.82 | +103.33% | 2 | Jan 27, 2025 | |
| ARGX argenx SE | Initiates: Buy | $390 | $637.40 | -38.81% | 1 | Jun 18, 2021 | |
| GLPG Galapagos NV | Downgrades: Neutral | n/a | $31.67 | - | 2 | Dec 20, 2019 |
ResMed
Aug 1, 2025
Maintains: Buy
Price Target: $285 → $325
Current: $283.29
Upside: +14.72%
Telix Pharmaceuticals
Jan 27, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $10.82
Upside: +103.33%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $637.40
Upside: -38.81%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $31.67
Upside: -